Trends of Over-the-Counter and Prescribed Medication Use During Pregnancy: A Cross-Sectional Study. Journal of Multidisciplinary Healthcare 2023: :16 3847–3856. doi: 10.2147/JMDH.S421087. (2023). Multidisciplinary Healthcare.

Erectile Dysfunction: Pharmacological Pathways with Understudied Potentials. Biomedicines 2023. 11 (1), 46, https://doi.org/10.3390/biomedicines11010046. (2023). Erectile Dysfunction.

Alanood Howsawi, Manal Alem (2023). Glycemic variability in patients with type 2 diabetes mellitus: clinical implications and pharmacological considerations. considerations. Journal of Hypertension, Volume 41, Supplement 3, June 2023, pp. e151-e151(1). (2023).

Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study. Journal of Hypertension, Volume 41, Supplement 3, June 2023. (2023).

Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study. Heliyon 2022. Nov 9;8 (11):e11549. doi:10.1016/j.heliyon.2022.e11549. (2022). Diabetes Mellitus.

Red Blood Cell Distribution Width (RDW) in Chronic Heart Failure: Does it have a Prognostic Value in Every Population? Electronic Journal of General Medicine 2021: 19 (1): em338. doi.org/10.29333/ejgm/11400. (2021). Electronic Journal of General Medicine.

Clinical, echocardiographic, and therapeutic characteristics of heart failure in patients with preserved, mid-range, and reduced ejection fraction: Future directions. International Journal of General Medicine. 2021: 14 459- 467. (2021). International Journal of General Medicine.

Manal Alem, Sarah R. Aldosari, Alhassna A. Alkahmous, Adam S. Obad, Nagy M. Fagir, Bandar S. Al-Ghamdi (2020). Effect of long term allopurinol therapy on left ventricular mass in patients with ischemic heart disease; a cross-sectional study. (2021).

Glycemic Variability in Patients with Type 2 Diabetes Mellitus: Clinical Implications and Pharmacological Considerations. Manuscript submitted for publication. (2020). Diabetes Mellitus.

Predictors of Mortality in Patients with Chronic Heart Failure: Is hyponatremia a useful clinical biomarker? International Journal of General Medicine. 2020:13 407–417. doi.org/10.2147/IJGM.S260256. (2020). International Journal of General Medicine.

Inter-relationships between left ventricular mass, geometry and arterial stiffness in patients with chronic heart failure. Journal of International Medical Research 48(4) 1–15. doi.org/10.1177%2F0300060520903623. (2020). Journal of International Medical Research.

Endothelial dysfunction in chronic heart failure; assessment, findings, significance, and potential therapeutic targets. International Journal of Molecular Sciences. 20 (13); 3198; doi:10.3390/ijms20133198. (2019). International Journal of Molecular Sciences.

Effect of long term allopurinol therapy on left ventricular mass in patients with ischemic heart disease; a cross-sectional study. Vascular Health and Risk Management 2019:15 539–550. doi: 10.2147/VHRM. S226009. (2019). Vascular Health and Risk Management.

Biological markers of oxidative stress and allopurinol therapy; a meta- analysis of randomized controlled trials. Journal of Pharmacology and Therapeutic Research 2(1):7-16. (2018). Journal of Pharmacology and Therapeutic Research.

Allopurinol and Endothelial function: A Systematic Review with Meta- Analysis of Randomized Controlled Trials. Cardiovascular Therapeutics. Aug; 36 (4); e12432. DOI: 10.1111/1755-5922.12432. (2018). Cardiovascular Therapeutics.

Effect of xanthine oxidase inhibition on arterial stiffness in patients with chronic heart failure. Clinical Medicine Insights: Cardiology 12: 1-10. DOI: 10.1177/1179546818779584. (2018). Clinical Medicine Insights.

Allopurinol and arterial stiffness-what do we know so far? Journal of Pharmacology and Therapeutic Research 1(1): 1. (2017). Journal of Pharmacology and Therapeutic Research.

Effect of xanthine oxidase inhibition on arterial stiffness in patients with chronic heart failure. failure. Journal of Hypertension. Jun; 33 Suppl 1: e47. (2015).

Comparison of the effects of diuretics on blood pressure and arterial stiffness in patients with stroke. Journal of stroke and cerebrovascular disease. Nov; 17(6): 373-377. (2008). Journal of Stroke and Cerebrovascular Disease.

Angiotensin-II receptor blockers: their place in hypertension. Prescriber. Aug; 18 (15): 24-29. (2007). Angiotensin-II Receptor Blockers.

Inhibition of nitric oxide increases arterial stiffness in type 2 diabetic patients. Diabetic Medicine. Jul; 24 (7): 803-804. (2007). Diabetic Medicine.

Comparison of the effect of diuretics on carotid blood flow in stroke patients. Journal of Cardiovascular Pharmacology 2006 Mar; 47 (3):446-469. (2006). Journal of Cardiovascular Pharmacology.

Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with type 2 diabetes. Diabetic Medicine. 2006 April; 23 (4): 398-402. (2006). Diabetic Medicine.

Comparison of the effects of diuretics on blood pressure and arterial stiffness in stroke patients. Cerebrovascular disease. Vol. 19, Suppl. 2. (2005).

Comparison of the effects of diuretics on blood pressure and arterial stiffness in stroke patients . (2005).

“Arterial stiffness in health and disease”. A thesis submitted for the degree of Doctor of Philosophy in the faculty of medicine of the University of Glasgow. (2005). University of Glasgow, UK.

AIIAS: their place in hypertension, nephropathy and heart failure. Prescriber. 2004 Jul; 15 (14): 14-21. (2004). Nephropathy and Heart Failure.

The effect of hormonal replacement therapy (HRT) on arterial stiffness in postmenopausal women. (2004).

Arterial stiffness in type 2 diabetes: altered pattern of response to systemic NOS inhibition. Diabetes 2004 53 Supplement 2 (Poster 697). (2004).

Arterial stiffness in type 2 diabetes: altered pattern of response to systemic NOS inhibition. J Hypertension. Vol 22, Suppl. 2: S194-S195. (2004).